Tarlatamab improves symptom and functional outcomes in extensive-stage small cell lung cancer
New trial shows tarlatamab improves symptoms for lung cancer patients
This Phase 3 randomized controlled trial of 509 adults with extensive-stage small cell lung cancer found that tarlatamab improved several pa…
A new trial shows tarlatamab helps patients with small cell lung cancer manage symptoms like coughing and chest pain better than standard ch…
Review of T cell engagers highlights potential for treating solid tumors and small cell lung cancer cases
Review of tarlatamab for solid tumors and small cell lung cancer
This review examines T cell engagers as a promising intervention for solid tumors, specifically small cell lung cancer. Current data suggest…
This review looks at tarlatamab, a T cell engager, for treating solid tumors and small cell lung cancer. It examines how these drugs work.